psoriasis. Psoriasis vulgaris
Conditions
Interventions
Treatment - Drugs
Placebo
Sponsors
Islamic Azad University, Pharmaceutical Sciences Branch
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients older than 18 years old; patients with low-to-severe plaque Psoriasis lesions are symmetric; no other underlying disease or are not pregnant; patients who do not receive treatment or previous treatment for at least two weeks before they are cut. Exclusion criteria: in case of dissatisfaction and sensitivity; patients who did not complete the treatment process and do not continue; pregnancy and lactation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Redness, thickness, scaling and involved area.2. PASI score(psoriasis area & severity index). Timepoint: Week 0 (baseline), week 3,6,9 to complete the follow-up. Method of measurement: 1. Psoriasis questionnaire/ 2. Psoriasis quality of life questionnaire/3. photography: before, during &after treatment/4. PASI calculator. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reported side effects (systemic and local). Timepoint: Patients were given a telephone number to call during treatment. Patient could report any side effects 24/7 as well as during follow-ups, all the way through the treatment and after completion. Method of measurement: Vigorous medical examination by the consultant dermatology, Questionnaire, photography, scoring. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed